Peptides MEX / Comparisons
BPC-157 vs TB-500: molecules, fragments and studies
BPC-157 and TB-500 do not denote the same sequence. TB-500 also requires an identity distinction: an analytical study identified the acetylated fragment Ac-LKKTETQ, which does not make every material carrying that name full-length thymosin β4.
Updated · Sources and editorial standards
| Feature | BPC-157 | TB-500 |
|---|---|---|
| Identity in the sources[2][1] | BPC-157 pentadecapeptide | Ac-LKKTETQ identified in the analyzed sample |
| Featured evidence type[2][3] | Rat tendon experiments | Chemical characterization and equine detection |
| Evaluated outcome[2][3] | Tendon-cell behavior | Compound/metabolite identity and presence |
Fifteen residues versus a seven-residue fragment
The 2012 TB-500 characterization study used chromatography and mass spectrometry to identify an acetylated fragment corresponding to thymosin β4 residues 17–23. BPC-157 contains 15 residues. That analyzed fragment should not be called a tetrapeptide or automatically assigned the properties of the full-length protein.
A biological question and an analytical question
The cited BPC-157 investigation examined tendon cells and their behavior. The TB-500 work identified a substance and developed detection strategies. A migration-assay signal and identification of a mass-spectrometry peak answer different questions; the latter is not evidence of tissue repair.
What equine samples show
A second study identified Ac-LKKTETQ and metabolites in equine plasma and urine. Its objective was analytical detection of TB-500 exposure. It did not evaluate human injury outcomes, and finding metabolites does not establish a clinical comparison of duration or efficacy with BPC-157.
Sources: [3]
Questions about this reference
Does a full-length thymosin β4 study establish a TB-500 result?
A study applies to the entity it actually investigated. Characterizing a seven-residue fragment does not establish equivalence to the full-length protein or confirm the identity of another vial.
Sources and original reading
- Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential
- The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration
- Doping control analysis of TB-500, a synthetic version of an active region of thymosin β4, in equine urine and plasma by liquid chromatography-mass spectrometry
Content updated: . How this content is prepared and checked.